SEARCH

SEARCH BY CITATION

References

  • Adams, Jr, H.P., Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L. & Marsh, III, E.E. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24, 3541.
  • Benchenane, K., Lopez-Atalaya, J.P., Fernandez-Monreal, M., Touzani, O. & Vivien, D. (2004) Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends in Neurosciences, 27, 155160.
  • van den Bosch, M.A., Kemmeren, J.M., Tanis, B.C., Mali, W.P., Helmerhorst, F.M., Rosendaal, F.R., Algra, A. & van der Graaf, Y. (2003) The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. Journal of Thrombosis and Haemostasis, 1, 439444.
  • Chan, M.Y., Andreotti, F. & Becker, R.C. (2008) Hypercoagulable states in cardiovascular disease. Circulation, 118, 22862297.
  • Colman, R.W. & Schmaier, A.H. (1997) Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood, 90, 38193843.
  • Guimaraes, A.H., de Bruijne, E.L., Lisman, T., Dippel, D.W., Deckers, J.W., Poldermans, D., Rijken, D.C. & Leebeek, F.W. (2009) Hypofibrinolysis is a risk factor for arterial thrombosis at young age. British Journal of Haematology, 145, 115120.
  • Kemmeren, J.M., Tanis, B.C., van den Bosch, M.A., Bollen, E.L., Helmerhorst, F.M., van der Graaf, Y., Rosendaal, F.R. & Algra, A. (2002) Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke, 33, 12021208.
  • Kilpatrick, T.J., Matkovic, Z., Davis, S.M., McGrath, C.M. & Dauer, R.J. (1993) Hematologic abnormalities occur in both cortical and lacunar infarction. Stroke, 24, 19451950.
  • Lisman, T., Leebeek, F.W., Mosnier, L.O., Bouma, B.N., Meijers, J.C., Janssen, H.L., Nieuwenhuis, H.K. & de Groot, P.G. (2001) Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology, 121, 131139.
  • Lisman, T., de Groot, P.G., Meijers, J.C. & Rosendaal, F.R. (2005) Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood, 105, 11021105.
  • Lloyd-Jones, D., Adams, R.J., Brown, T.M., Carnethon, M., Dai, S., De, S.G., Ferguson, T.B., Ford, E., Furie, K., Gillespie, C., Go, A., Greenlund, K., Haase, N., Hailpern, S., Ho, P.M., Howard, V., Kissela, B., Kittner, S., Lackland, D., Lisabeth, L., Marelli, A., McDermott, M.M., Meigs, J., Mozaffarian, D., Mussolino, M., Nichol, G., Roger, V.L., Rosamond, W., Sacco, R., Sorlie, P., Roger, V.L., Thom, T., Wasserthiel-Smoller, S., Wong, N.D. & Wylie-Rosett, J. (2010) Heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation, 121, e46e215.
  • Meltzer, M.E., Doggen, C.J.M., de Groot, P.G., Rosendaal, F.R. & Lisman, T. (2007) Fibrinolysis and the risk of venous and arterial thrombosis. Current Opinion Hematology, 14, 242248.
  • Meltzer, M.E., Lisman, T., Doggen, C.J.M., de Groot, P.G. & Rosendaal, F.R. (2008) Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis. PLoS Medicine, 5, e97.
  • Meltzer, M.E., Doggen, C.J.M., de Groot, P.G., Rosendaal, F.R. & Lisman, T. (2009) Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men. British Journal of Haematology, 145, 121127.
  • Meltzer, M.E., Lisman, T., de Groot, P.G., Meijers, J.C.M., le Cessie, S., Doggen, C.J.M. & Rosendaal, F.R. (2010) Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood, 116, 113121.
  • Prins, M.H. & Hirsh, J. (1991) A critical review of the relationship between impaired fibrinolysis and myocardial infarction. American Heart Journal, 122, 545551.
  • Rosendaal, F.R. (2003) Clotting and myocardial infarction: a cycle of insights. Journal of Thrombosis and Haemostasis, 1, 640642.
  • Sharma, S.C., Vijayan, G.P., Seth, H.N. & Suri, M.L. (1978) Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in young patients with ischaemic stroke. Journal of Neurology, Neurosurgery and Psychiatry, 41, 118121.
  • Tanis, B.C., van den Bosch, M.A., Kemmeren, J.M., Manger Cats, V., Helmerhorst, F.M., Algra, A., van der Graaf, Y. & Rosendaal, F.R. (2001) Oral contraceptives and the risk of myocardial infarction. New England Journal Medicine, 345, 17871793.
  • Tsantes, A.E., Nikolopoulos, G.K., Bagos, P.G., Tsiara, C.G., Kapsimali, V., Travlou, A. & Vaiopoulos, G. (2007) Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysis. Blood Coagulation and Fibrinolysis, 18, 497504.
  • Tsantes, A.E., Nikolopoulos, G.K., Bagos, P.G., Bonovas, S., Kopterides, P. & Vaiopoulos, G. (2008) The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk. Thrombosis Research, 122, 736742.
  • Undas, A., Celinska-Lowenhoff, M., Lowenhoff, T. & Szczeklik, A. (2006) Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. Journal of Thrombosis and Haemostasis, 4, 10291036.